449 related articles for article (PubMed ID: 11315988)
1. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
Silverberg SJ; Gao P; Brown I; LoGerfo P; Cantor TL; Bilezikian JP
J Clin Endocrinol Metab; 2003 Oct; 88(10):4725-30. PubMed ID: 14557447
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
6. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.
John MR; Goodman WG; Gao P; Cantor TL; Salusky IB; Jüppner H
J Clin Endocrinol Metab; 1999 Nov; 84(11):4287-90. PubMed ID: 10566687
[TBL] [Abstract][Full Text] [Related]
7. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
8. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
Rajala MM; Klee GG; Heath H
J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
[TBL] [Abstract][Full Text] [Related]
9. Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.
Gao P; Schmidt-Gayk H; Dittrich K; Nolting B; Maier A; Roth HJ; Seemann O; Reichel H; Ritz E; Schilling T
Clin Chim Acta; 1996 Feb; 245(1):39-59. PubMed ID: 8646814
[TBL] [Abstract][Full Text] [Related]
10. Validation and clinical utility of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone in the horse.
Estepa JC; Garfia B; Gao PR; Cantor T; Rodriguez M; Aguilera-Tejero E
Equine Vet J; 2003 May; 35(3):291-5. PubMed ID: 12755433
[TBL] [Abstract][Full Text] [Related]
11. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay.
Yamashita H; Gao P; Noguchi S; Cantor T; Uchino S; Watanabe S; Yamashita H; Kawamoto H; Fukagawa M
Ann Surg; 2002 Jul; 236(1):105-11. PubMed ID: 12131092
[TBL] [Abstract][Full Text] [Related]
13. Optimizing efficacy of quick parathyroid hormone determination in the operating theater.
Mengozzi G; Baldi C; Aimo G; Mullineris B; Salvo R; Biasiol S; Pagni R; Gasparri G
Int J Biol Markers; 2000; 15(2):153-60. PubMed ID: 10883889
[TBL] [Abstract][Full Text] [Related]
14. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
Ikeda Y; Kurihara H; Morita N; Miyabe R; Takami H
J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
[TBL] [Abstract][Full Text] [Related]
15. Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism.
Yamashita H; Cantor T; Uchino S; Watanabe S; Ogawa T; Moriyama T; Takamatsu Y; Fukagawa M; Noguchi S
World J Surg; 2005 Feb; 29(2):169-73. PubMed ID: 15650804
[TBL] [Abstract][Full Text] [Related]
16. [Significance of a new PTH assay (the comparison between whole-PTH and intact-PTH assay)].
Ito N; Fukumoto S
Clin Calcium; 2004 Sep; 14(9):55-6. PubMed ID: 15577110
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
[TBL] [Abstract][Full Text] [Related]
18. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
[TBL] [Abstract][Full Text] [Related]
19. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism.
Yamashita H; Gao P; Cantor T; Noguchi S; Uchino S; Watanabe S; Ogawa T; Kawamoto H; Fukagawa M
Surgery; 2004 Feb; 135(2):149-56. PubMed ID: 14739849
[TBL] [Abstract][Full Text] [Related]
20. Determination of bioactive rat parathyroid hormone (PTH) concentrations in vivo and in vitro by a 2-site homologous immunoradiometric assay.
Schultz VL; Garner SC; Lavigne JR; Toverud SU
Bone Miner; 1994 Nov; 27(2):121-32. PubMed ID: 7711520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
